January 2021

A digital approach to end-of-life planning

A team in a Stanford Biodesign course that pairs computer science students with physicians developed an app designed to prompt end-of-life conversations.

Based on genes, nearly everyone is likely to have an atypical response to at least one drug

Stanford Medicine researchers found that, based on genetic makeup, 99.5% of people are likely to have an atypical response to at least one drug.